Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


HU25 Maxi-Plus Standard: High throughput separations with the maxi-plus standard horizontal

Product Description
Scie-Plas™ Green Range™ horizontal gel electrophoresis units offer the ultimate standards in innovative design and manufacture, acquired during our 20-year existence. The Scie-Plas Green Range horizontal gel electrophoresis units currently comprise models with gel tray sizes ranging from 6 x 7.5 to 25 x 30cm. All models incorporate many design and safety features recommended by scientists, either from within our in-house product development team or laboratories worldwide. As a result, all our models are manufactured and finished to the highest specification, easy to use, and, with safety always paramount, CE-marked - conforming to European safety regulations.

The HU25 Maxi-Plus standard horizontal gel unit is designed specifically for high throughput screening of nucleic acids, particularly PCR products and in genotyping studies. A 25 x 30cm gel-casting tray, with 12 positions for multichannel-compatible combs, accommodates a maximum throughput of 624 samples. Buffer recirculation ports are included as standard to prevent buffer depletion and ion gradient formation during long-distance separations. Casting gates with integral silicone seals provide leak-free and tape-free gel-casting either within the tank or externally, whereas HU25-SS Scie-Plas Super-Seals give the user the option of flexible gel-casting.

FEATURES

Complete System
Maxi-plus standard horizontal gel unit with removable casting tray, including casting gates with integral silicone seals, 6 x 1mm thick, 26-sample combs, coloured loading strips and buffer recirculation ports
Unit Dimensions (W x L x H): 33 x 56 x 9cm
Gel Size (W x L): 25 x 30cm
Buffer Volume: 3000ml
Maximum Sample Capacity: 624
Recommended Power Supplies: Consort EV243
Product HU25 Maxi-Plus Standard: High throughput separations with the maxi-plus standard horizontal
Company Scie-Plas Ltd
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity 1
Company Logo

Scie-Plas Ltd
22 Cambridge Science Park Milton Road Cambridge CB4 0FJ UK

Tel: +44 (0) 1223 427888
Fax: +44 (0) 1223 420164
Email: Sales@scie-plas.co.uk



Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be pair with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Sensor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!